50 million US adults now use GLP‑1 drugs, increasing protein intake ~65%. Whey prices are up 50%+ YTD, and some protein manufacturers have sold out for the year. BRBR’s Premier Protein is one of the few brands that passed heavy‑metal tests, giving it a quality moat that can capture the GLP‑1‑driven demand surge. As a publicly traded pure‑play protein powder company with strong brand recognition, BRBR is poised to benefit from a structural demand shift that the market has not fully priced in. Rising whey input costs could compress margins; increased competition from cheaper alternatives (cottage cheese, plant‑based), and the GLP‑1 trend may slow or face regulatory headwinds.
50 million US adults now use GLP‑1 drugs, increasing protein intake ~65%. Whey prices are up 50%+ YTD, and some protein manufacturers have sold out for the year. BRBR’s Premier Protein is one of the few brands that passed heavy‑metal tests, giving it a quality moat that can capture the GLP‑1‑driven demand surge. As a publicly traded pure‑play protein powder company with strong brand recognition, BRBR is poised to benefit from a structural demand shift that the market has not fully priced in. Rising whey input costs could compress margins; increased competition from cheaper alternatives (cottage cheese, plant‑based), and the GLP‑1 trend may slow or face regulatory headwinds.